Kate Lapane to Hypoglycemic Agents
This is a "connection" page, showing publications Kate Lapane has written about Hypoglycemic Agents.
Rajpathak SN, Fu C, Brodovicz KG, Engel SS, Lapane K. Sulfonylurea use and risk of hip fractures among elderly men and women with type 2 diabetes. Drugs Aging. 2015 Apr; 32(4):321-7.
Dore DD, Trivedi AN, Mor V, Lapane KL. Association between extent of thiazolidinedione exposure and risk of acute myocardial infarction. Pharmacotherapy. 2009 Jul; 29(7):775-83.
Allsworth JE, Toppa R, Palin NC, Lapane KL. Racial and ethnic disparities in the pharmacologic management of diabetes mellitus among long-term care facility residents. Ethn Dis. 2005; 15(2):205-12.
Allsworth JE, Toppa R, Palin NC, Lapane KL. For the patient. Many nursing home patients do not receive diabetes medicine. Ethn Dis. 2005; 15(2):351.
Lapane KL, Jesdale BM, Dubé CE, Pimentel CB, Rajpathak SN. Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2015 Aug; 109(2):411-9.
Spooner JJ, Lapane KL, Hume AL, Mor V, Gambassi G. Pharmacologic treatment of diabetes in long-term care. J Clin Epidemiol. 2001 May; 54(5):525-30.